Newly published research led by the Minneapolis Heart Institute Foundation and Tufts Medical Center in Boston shows that implantable defibrillators (ICDs), along with other modern treatments, have reduced mortality rates and are helping patients with hypertrophic cardiomyopathy (HCM) live longer, including normal life expectancy.
from The Medical News http://ift.tt/1MthzOu
from The Medical News http://ift.tt/1MthzOu
No comments:
Post a Comment